Catalyst Pharmaceuticals Inc (CPRX)

Net profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	71,410	62,037	115,549	99,406	83,079	66,917	54,498	45,060	39,482	41,610	74,621	72,220	74,983	71,476	41,766	42,946	31,875	9,445	-12,024	-28,949
Revenue (ttm)	US$ in thousands	398,204	348,393	302,949	256,480	214,203	191,755	170,465	153,717	140,833	133,539	126,902	120,142	119,073	118,181	119,761	118,994	102,306	72,683	41,786	12,948
Net profit margin		17.93%	17.81%	38.14%	38.76%	38.79%	34.90%	31.97%	29.31%	28.03%	31.16%	58.80%	60.11%	62.97%	60.48%	34.87%	36.09%	31.16%	12.99%	-28.78%	-223.58%

December 31, 2023 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $71,410K ÷ $398,204K
= 17.93%

The net profit margin of Catalyst Pharmaceuticals Inc has shown fluctuations over the past 20 quarters. The margin ranged from -223.58% in the first quarter of 2019 to a high of 62.97% in the first quarter of 2021. In the most recent quarter, the net profit margin was 17.93%, reflecting a profitable operational performance. Overall, the company has demonstrated varying levels of profitability over time, with the margin generally showing improvement from negative figures to positive values in recent quarters.